Third Rock Ventures IV, L.P., Ten Percent Owner at Dianthus Therapeutics, holds 19.20M shares in Tango Therapeutics (Ticker: TNGX), holds 3.06M shares in Dianthus Therapeutics (Ticker: DNTH), holds 1.42M shares in Revolution Medicines (Ticker: RVMD). Most recently, Third Rock Ventures IV, L.P. Sold ― shares of Tango Therapeutics on Feb 21, 2024 for an estimated value of 1.95M.